Cardiovascular Diseases

January 22, 2021

The approval come following the results of a phase 3 trial.

January 18, 2021

The prevalence of heart failure is increasing as the demographic profile of the American population gets older.

January 18, 2021

Attention is turning this year to heart failure with preserved injection fraction.

January 12, 2021

A remote monitoring system detects indicators of worsening heart failure.

January 11, 2021

Philip Adamson, M.D., M.Sc., details the relationship between cardiovascular manifestations and COVID-19.

January 05, 2021

Using AI and real-world data, investigators identify drugs that can be used to treat heart disease.

December 28, 2020

New study findings demonstrate patients with treatment-resistant hypertension rarely get tested for primary aldosteronism.

December 21, 2020

December 16, 2020

The panel supports an expanded indication but struggles to reach consensus on what an expanded label might look like.

December 14, 2020

The NDA submission comes following the results of a phase 3a trial.

December 11, 2020

Women have an increased risk of heart disease in the years leading up to menopause.

December 10, 2020

The idea that social factors affect health outcomes is not new, but new research suggests total number of social determinants of health is a valuable proxy for coronary heart disease risk.

December 08, 2020

Women are disproportionately affected by heart failure after heart attacks, according to a Canadian study.

December 07, 2020

While glucocorticoids are widely used to reduce inflammation in patients with many inflammatory diseases, doctors don’t know whether a low to moderate glucocorticoid dose increases cardiovascular risk.

November 29, 2020

FDA approves several drugs to treat rare conditions in both cancer and metabolic diseases.

November 18, 2020

Entresto (sacubitril-valsartan) didn’t get a lot of love from payers after it was approved in 2015 because of its expense and the crowded armamentarium for heart failure. But Entresto has since made its way into guidelines for reduced ejection fraction heart failure, sometimes called systolic heart failure.

November 17, 2020

Updates from the American Heart Association Scientific Sessions.

November 15, 2020

A Cleveland Clinic scientist stopped short of saying doctors should take patients off Vascepa, but he said he has questions due to the lack of a "neutral comparator."

November 13, 2020

Overall, the Polycap polypill (simvastatin, atenolol, hydrochlorothiazide, ramipril) falls well short of the high expectations for the polypill approach to cardiovascular disease risk reduction.

November 13, 2020

The findings are the first in a series of six studies involving a registry supported by drug makers in the diabetes, cardiovascular, and heart failure space.